FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...
A discussion of his situation led to the selection of the enVista Envy IOL. One month postoperatively, the patient achieved ...
Please provide your email address to receive an email when new articles are posted on . Eyes that received LipiFlow treatment before cataract surgery had improved meibomian gland scores compared with ...
Aging is a natural part of life, and as we grow older, our bodies go through various changes. Our hair turns gray, our joints ache a bit more and our energy levels fluctuate. But one aspect of aging ...
Vivity complements Alcon’s existing IOL portfolio by providing an additional option for cataract patients to treat presbyopia A first-of-its-kind, non-diffractive lens that offers a continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results